Uscom Ltd (AU:UCM) — Market Cap & Net Worth
Market Cap & Net Worth: Uscom Ltd (UCM)
Uscom Ltd (AU:UCM) has a market capitalization of $2.21 Million (AU$3.12 Million) as of September 24, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29987 globally and #1745 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Uscom Ltd's stock price AU$0.01 by its total outstanding shares 260147121 (260.15 Million). Also see UCM total assets for a full breakdown of the balance sheet.
Uscom Ltd Market Cap History: 2015 to 2026
Uscom Ltd's market capitalization history from 2015 to 2026. Data shows change from $31.88 Million to $2.21 Million (-20.79% CAGR). Also see Uscom Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Uscom Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Uscom Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check UCM live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.86x
Uscom Ltd's market cap is 0.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $44.64 Million | $2.94 Million | -$1.92 Million | 15.20x | N/A |
| 2017 | $38.27 Million | $3.50 Million | -$1.80 Million | 10.94x | N/A |
| 2018 | $26.41 Million | $2.86 Million | -$1.96 Million | 9.23x | N/A |
| 2019 | $21.87 Million | $3.64 Million | -$1.39 Million | 6.00x | N/A |
| 2020 | $29.16 Million | $3.48 Million | -$1.33 Million | 8.38x | N/A |
| 2021 | $21.17 Million | $3.86 Million | -$924.24K | 5.49x | N/A |
| 2022 | $8.28 Million | $2.51 Million | -$1.97 Million | 3.30x | N/A |
| 2023 | $7.55 Million | $2.66 Million | -$2.59 Million | 2.83x | N/A |
| 2024 | $5.89 Million | $3.73 Million | -$2.07 Million | 1.58x | N/A |
| 2025 | $2.21 Million | $2.58 Million | -$3.30 Million | 0.86x | N/A |
Competitor Companies of UCM by Market Capitalization
Companies near Uscom Ltd in the global market cap rankings as of September 24, 2026. Review Uscom Ltd tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Uscom Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Uscom Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Uscom Ltd's market cap moved from $31.88 Million to $ 2.21 Million, with a yearly change of -20.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$2.21 Million | 0.00% |
| 2025 | AU$2.21 Million | -62.50% |
| 2024 | AU$5.89 Million | -21.95% |
| 2023 | AU$7.55 Million | -8.89% |
| 2022 | AU$8.28 Million | -60.87% |
| 2021 | AU$21.17 Million | -27.40% |
| 2020 | AU$29.16 Million | +33.33% |
| 2019 | AU$21.87 Million | -17.21% |
| 2018 | AU$26.41 Million | -30.98% |
| 2017 | AU$38.27 Million | -14.27% |
| 2016 | AU$44.64 Million | +40.01% |
| 2015 | AU$31.88 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Uscom Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.21 Million USD |
| MoneyControl | $2.21 Million USD |
| MarketWatch | $2.21 Million USD |
| marketcap.company | $2.21 Million USD |
| Reuters | $2.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Uscom Ltd
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more